cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery

Pflugers Archiv European Journal of Physiology

Volumn 454, Issue 6, 2007, Pages 913-923

  Qin, Xue ^a   Zheng, Xiaoxu ^a   Qi, Hui ^a   Dou, Dou ^a   Raj, J Usha ^c   Gao, Yuansheng ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Basal tension; cGMP; Myristoylated PKI; Relaxation; Rp 8 Br PET cGMPS

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLYCERYL TRINITRATE; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CORONARY ARTERY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; TISSUE HOMOGENATE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BLOTTING, WESTERN; CORONARY VESSELS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DIFFUSION CHAMBERS, CULTURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MUSCLE RELAXATION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGLYCERIN; SWINE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 34548331154     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-007-0249-8     Document Type: Article

References (49)

1. Algara-Suarez P, Espinosa-Tanguma R (2004) 8-Br-cGMP mediates relaxation of tracheal smooth muscle through PKA. Biochem Biophys Res Commun 314:597-601
2. 2+ sensitivity by cyclic nucleotides in smooth muscle from protein kinase G deficient mice. J Biol Chem 279:5146-5151
3. Bradford MM (1973) A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Chem 72:249-254
4. Busse R, Fleming I (2003) Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol Sci 24:24-29
5. Butt E, Pohler D, Genieser HG, Huggins JP, Bucher B (1995) Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS. Br J Pharmacol 116:3110-3116
6. Coleman RA, Humphrey PP, Kennedy I, Levy GP, Lumley P (1981) Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73:773-778
7. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM (1994) Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267:1405-1413
8. Corriu C, Feletou M, Puybasset L, Bea ML, Berdeaux A, Vanhoutte PM (1998) Endothelium-dependent hyperpolarization in isolated arteries taken from animals treated with NO-synthase inhibitors. J Cardiovasc Pharmacol 32:944-950
9. De la Lande IS, Stafford I, Horowitz JD (1999) Effects of guanylyl cyclase and protein kinase G inhibitors on vasodilatation in non-tolerant and tolerant bovine coronary arteries. Eur J Pharmacol 370:39-46
10. Dhanakoti S, Gao Y, Nguyen MQ, Raj JU (2000) Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol 88:1637-1642
11. Feil R, Gappa N, Rutz M (2002) Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms. Circ Res 90:1080-1086
12. Francis SH, Noblett BD, Todd BW, Wells JN, Corbin JD (1988) Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol Pharmacol 34:506-517
13. Francis SH, Corbin JD (1994) Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase. Adv Pharmacol 26:115-170
14. Francis SH, Corbin JD (1994) Structure and function of cyclic nucleotide-dependent protein-kinases. Annu Rev Physiol 56:237-272
15. Gao Y, Zhou H, Ibe BO, Raj JU (1996) Prostaglandin E2 and I2 cause greater relaxations in pulmonary veins than in arteries of newborn lambs. J Appl Physiol 81:2534-2539
16. Gao Y, Dhanakoti S, Tolsa J-F, Raj JU (1999) Role of protein kinase G in nitric oxide- and cGMP-induced relaxation of newborn ovine pulmonary veins. J Appl Physiol 87:993-998
17. Garthwaite J, Southam E, Boulton CL (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4, 3-a]quinoxalin-1-one. Mol Pharmacol 48:184-188
18. Gillespie PC (1990) Phosphodiesterases in visual transduction by rods and cones. In: Beavo J, Houslay MD (eds) Cyclic nucleotide phosphodiesterases: structure, regulation and drug action. Wiley, New York, pp 163-184
19. Glass DB, Krebs EG (1982) Phosphorylation by guanosine 3′,5′-monophosphate-dependent protein kinase of synthetic peptide analogs of a site phosphorylated in histone H2B. J Biol Chem 257:1196-1200
20. Hofmann F, Ammendola A, Schlossmann J (2000) Rising behind NO: cGMP-dependent protein kinase. J Cell Sci 113:1671-1676
21. Hofmann F, Feil R, Kleppisch T, Schlossmann J (2006) Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86:1-23
22. Ignarro LJ (2002) Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 53:503-514
23. Jiang H, Colbran JL, Francis SH, Corbin JD (1992) Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 267:1015-1019
24. 2+ desensitization of skinned rat artery. Eur J Pharmacol 323:75-82
25. Keefer LK, Nims RW, Davies KM (1996) "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268:281-293
26. Keilbach A, Ruth P, Hofmann F (1992) Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur J Biochem 208:467-473
27. Kenakin TP (1997) Pharmacologic analysis of drug-receptor interaction, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, USA
28. Keung W, Vanhoutte PM, Man RY (2005) Acute impairment of contractile responses by 17beta-estradiol is cAMP and protein kinase G dependent in vascular smooth muscle cells of the porcine coronary arteries. Br J Pharmacol 144:71-79
29. Lincoln TM, Dey N, Sellak H (2001) cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91:1421-1430
30. Lohmann SM, Walter U (2005) Tracking functions of cGMP-dependent protein kinase (cGK). Front Biosci 10:1313-1328
31. Melichar VO, Behr-Roussel D, Zabel U, Uttenthal LO, Rodrigo J, Rupin A, Verbeuren TJ, Kumar HSA, Schmidt HH (2004) Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci USA 101:16671-16676
32. Meyer RBJ, Miller JP (1974) Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci 14:1019-1040
33. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:58-65
34. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. New Engl J Med 329:2002-2012
35. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
36. 5-[imino (nitroamino) methyl]-l-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from l-arginine. Naunyn-Schmiedeberg's Arch Pharmacol 341:143-147
37. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiß C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F (1998) Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17:3045-3051
38. Quyyumi A, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO (1995) Nitric oxide activity in the human coronary circulation. J Clin Invest 95:1747-1755
39. Randriamboavonjy V, Kiss L, Falck JR, Busse R, Fleming I (2005) The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. Cardiovasc Res 65:487-494
40. Rivero-Vilches FJ, de Frutos S, Saura M, Rodriguez-Puyol D, Rodriguez-Puyol M (2003) Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP. Am J Physiol Cell Physiol 285:891-898
41. Schulz E, Tsilimingas N, Rinze R, Reiter B, Wendt M, Oelze M, Woelken-Weckmüller S, Walter U, Reichenspurner H, Meinertz T, Münzel T (2002) Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 105:1170-1175
42. Sekhar KR, Hatchett RJ, Shabb JB, Wolfe L, Francis SH, Wells JN, Jastorff B, Butt E, Chakinala MM, Corbin JD (1992) Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase. Mol Pharmacol 42:103-108
43. Schlossmann J, Hofmann F (2005) cGMP-dependent protein kinases in drug discovery. Drug Discov Today 10:627-634
44. Schwede F, Maronde E, Genieser H, Jastorff B (2000) Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol Ther 87:199-226
45. Su J, Scholz PM, Weiss HR (2005) Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes. Exp Biol Med 230:242-250
46. Vanhoutte PM (2003) Endothelial control of vasomotor function: from health to coronary disease. Circ J 67:572-575
47. Walsh DA, Ashby CD, Gonzalez C, Calkins D, Fischer EH, Krebs EG (1971) Purification and characterization of a protein inhibitor of adenosine 3′,5′-monophosphate-dependent protein kinase. J Biol Chem 246:1977-1985
48. B receptor-mediated contraction of rat pulmonary arteries. Am J Physiol 290:570-578
49. Yamahara K, Itoh H, Chun TH, Ogawa Y, Yamashita J, Sawada N, Fukunaga Y, Sone M, Yurugi-Kobayashi T, Miyashita K, Tsujimoto H, Kook H, Feil R, Garbers DL, Hofmann F, Nakao K (2003) Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci USA 100:3404-3409